Table 1.
Variable and category | Entire population (N=1,918,549), n (%) | Access to the swab (n=85,348), n (%) | Positivity to SARS-Cov-2 (n=12,793), n (%) | Hospitalization (n=4644), n (%) | Admitted to the ICUa (n=1508), n (%) | Death within 30 days (n=749), n (%) | |
Gender | |||||||
|
Male | 938,610 (48.9) | 32,129 (37.6) | 5961 (46.6) | 3075 (66.2) | 1118 (74.1) | 558 (74.5) |
Female | 979,939 (51.1) | 53,219 (62.4) | 6832 (53.4) | 1569 (33.8) | 390 (25.9) | 191 (25.5) | |
Age (years) | |||||||
|
45-59 | 1,062,861 (55.4) | 54,672 (64.1) | 7324 (57.2) | 1717 (37.0) | 503 (33.4) | 120 (16.0) |
60-74 | 855,688 (44.6) | 30,676 (35.9) | 5469 (42.8) | 2927 (63.0) | 1005 (66.6) | 629 (84.0) | |
Month of first swab | |||||||
|
February-March | N/Ab | 14,134 (16.6) | 5364 (41.9) | 3088 (66.5) | 1079 (71.5) | 502 (67.0) |
April-May | N/A | 71,214 (83.4) | 7429 (58.1) | 1556 (33.5) | 429 (28.5) | 247 (33.0) | |
CCIc | |||||||
|
0 | 1,442,666 (75.2) | 58,775 (68.8) | 8,620 (67.4) | 2,599 (56.0) | 837 (55.5) | 280 (37.4) |
1 | 335,685 (17.5) | 16,180 (19.0) | 2540 (19.8) | 1091 (23.5) | 361 (23.9) | 175 (23.3) | |
2-3 | 121,723 (6.3) | 8099 (9.5) | 1277 (10.0) | 710 (15.3) | 233 (15.5) | 199 (26.6) | |
4+ | 18,475 (1.0) | 2294 (2.7) | 356 (2.8) | 244 (5.2) | 77 (5.1) | 95 (12.7) | |
Oncological disease | 58,742 (3.1) | 3993 (4.7) | 525 (4.1) | 303 (6.5) | 83 (5.5) | 82 (11.0) | |
Cardiovascular disease | 136,335 (7.1) | 9239 (10.8) | 1480 (11.6) | 797 (17.2) | 252 (16.7) | 217 (29.0) | |
Respiratory disease | 50,328 (2.6) | 4792 (5.6) | 751 (5.9) | 426 (9.2) | 124 (8.2) | 129 (17.2) | |
Myocardial infarction | 40,288 (2.1) | 2416 (2.8) | 420 (3.3) | 278 (6.0) | 99 (6.6) | 78 (10.4) | |
Heart failure | 7,817 (0.4) | 762 (0.9) | 117 (0.9) | 79 (1.7) | 22 (1.5) | 28 (3.7) | |
Cerebrovascular disease | 23,753 (1.2) | 2197 (2.6) | 378 (2.9) | 186 (4.0) | 53 (3.5) | 72 (9.6) | |
Diabetes | 157,214 (8.2) | 8335 (9.8) | 1547 (12.1) | 896 (19.3) | 352 (23.3) | 239 (31.9) |
aICU: intensive care unit.
bN/A: not applicable.
cCCI: Charlson Comorbidity Index.